1. Home
  2. ZYXI vs IAE Comparison

ZYXI vs IAE Comparison

Compare ZYXI & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • IAE
  • Stock Information
  • Founded
  • ZYXI 1996
  • IAE 2007
  • Country
  • ZYXI United States
  • IAE United States
  • Employees
  • ZYXI N/A
  • IAE N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IAE Trusts Except Educational Religious and Charitable
  • Sector
  • ZYXI Health Care
  • IAE Finance
  • Exchange
  • ZYXI Nasdaq
  • IAE Nasdaq
  • Market Cap
  • ZYXI 66.5M
  • IAE 65.2M
  • IPO Year
  • ZYXI N/A
  • IAE N/A
  • Fundamental
  • Price
  • ZYXI $2.07
  • IAE $6.30
  • Analyst Decision
  • ZYXI Buy
  • IAE
  • Analyst Count
  • ZYXI 3
  • IAE 0
  • Target Price
  • ZYXI $6.00
  • IAE N/A
  • AVG Volume (30 Days)
  • ZYXI 229.1K
  • IAE 46.3K
  • Earning Date
  • ZYXI 04-29-2025
  • IAE 01-01-0001
  • Dividend Yield
  • ZYXI N/A
  • IAE 10.21%
  • EPS Growth
  • ZYXI N/A
  • IAE N/A
  • EPS
  • ZYXI N/A
  • IAE N/A
  • Revenue
  • ZYXI $172,401,000.00
  • IAE N/A
  • Revenue This Year
  • ZYXI N/A
  • IAE N/A
  • Revenue Next Year
  • ZYXI $23.16
  • IAE N/A
  • P/E Ratio
  • ZYXI N/A
  • IAE N/A
  • Revenue Growth
  • ZYXI N/A
  • IAE N/A
  • 52 Week Low
  • ZYXI $1.66
  • IAE $5.31
  • 52 Week High
  • ZYXI $11.15
  • IAE $6.45
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 40.51
  • IAE 61.98
  • Support Level
  • ZYXI $1.95
  • IAE $6.19
  • Resistance Level
  • ZYXI $2.19
  • IAE $6.33
  • Average True Range (ATR)
  • ZYXI 0.21
  • IAE 0.08
  • MACD
  • ZYXI 0.08
  • IAE 0.03
  • Stochastic Oscillator
  • ZYXI 45.05
  • IAE 90.24

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.

Share on Social Networks: